Get started
Author

Subha Shankar Das

Observed name: Subha Sankar Das
OpenAlex ID: A5014688213
Therapeutic efficacy of 225Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapy
2021 · Ishita Sen, Parul Thakral, et al. · Annals of Nuclear Medicine · 42
Potential Efficacy of 68Ga-Trivehexin PET/CT and Immunohistochemical Validation of αvβ6 Integrin Expression in Patients With Head and Neck Squamous Cell Carcinoma and Pancreatic Ductal Adenocarcinoma
2024 · Subha Shankar Das, Sunita Ahlawat, et al. · Clinical Nuclear Medicine · 32
Dosimetric analyses of intra-arterial versus standard intravenous administration of 177Lu-DOTATATE in patients of well differentiated neuroendocrine tumor with liver-dominant metastatic disease
2021 · Parul Thakral, Ishita Sen, et al. · British Journal of Radiology · 23
PDF
The Role of PET-CT-Guided Metabolic Biopsies in Improving Yield of Inconclusive Anatomical Biopsies: A Review of 5 Years in a Teaching Hospital
2023 · Dharmender Malik, Vineet Pant, et al. · Diagnostics · 14
PDF
Validation of In-House Kit-Like Synthesis of 68 Ga-Trivehexin and Its Biodistribution for Targeting the Integrin αvβ6 Expressing Tumors
2023 · Parul Thakral, Subha Shankar Das, et al. · Cancer Biotherapy and Radiopharmaceuticals · 9
Invasive Fungal Infection in COVID-19–Recovered Patient Detected on 18F-FDG–Labeled Leukocytes PET/CT Scan
2021 · Divya Manda, Ishita Sen, et al. · Clinical Nuclear Medicine · 8
Incremental Value of 18F-FDG–Labeled Leukocytes PET/CT Over 18F-FDG PET/CT Scan in the Detection of Occult Infection
2022 · Divya Manda, Parul Thakral, et al. · Clinical Nuclear Medicine · 5
Lead-203 VMT-α-Neuroendocrine Tumor Scintigraphy: A Promising Theranostics Agent
2024 · Parul Thakral, Ishita Barat Sen, et al. · Indian Journal of Nuclear Medicine · 4
Validation of Radiosynthesis and First in-Human Dosimetry of 68 Ga-NOTA-UBI-29-41: A Proof of Concept Study
2024 · Parul Thakral, Nishant Rana, et al. · Cancer Biotherapy and Radiopharmaceuticals · 3
Radioguided Surgery in Insulinoma Using 68Ga Labeled Exendin-4: a Case Report
2021 · Subha Shankar Das, Parul Thakral, et al. · Nuclear Medicine and Molecular Imaging · 2
Feasibility of 18 F-FDG Labelling of Leucocytes in a Centre Without an On-Site Cyclotron and Monitoring of Radiation Dose to Occupational Worker in the Labelling Procedure
2022 · Parul Thakral, Divya Manda, et al. · Cancer Biotherapy and Radiopharmaceuticals · 1
Effect of non-optimal ambient temperature on preterm birth and its heterogeneity in various social sub-groups: a report from the Indo Gangetic Plains of India
2026 · Aisurya Aswini Samal, Jagyenswar Rath, et al. · BMC Pregnancy and Childbirth
The Incremental Value of 18F FDG Labelled Leukocytes PET/CT Over 18F FDG PET/CT Scan in the Detection of Occult Infection
2021 · Divya Manda, Parul Thakral, et al. · Journal of Nuclear Medicine
Dosimetric analyses of intra-arterial versus standard intravenous administration of lutetium-177-DOTA octreotate in patients with Neuroendocrine tumour liver dominant metastatic disease
2021 · Parul Thakral, Ishita Sen, et al. · Journal of Nuclear Medicine
Role of serial 18F-FDG PET CT in evaluation of functional recovery and substrate normalization following CABG in patients with hibernating myocardium and left ventricular dysfunction
2020 · Kanchan Sharma, Udgeath Dhir, et al. · Journal of Nuclear Medicine
Intra-Arterial Peptide Receptor Radionuclide Therapy (PRRT) with Lutetium (177Lu) DOTATATE for Neuroendocrine tumour Liver dominant metastatic disease -Initial experience
2020 · Subha Shankar Das, Saurabh Kumar, et al. · Journal of Nuclear Medicine
Works count: 16
Citation count: 143
H-index: 6
I10-index: 4
Year
Topic
Type